Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
==============================================================================================================================================================

* MacLean S. Hall
* Jamie K. Teer
* Xiaoqing Yu
* Holly Branthoover
* Sebastian Snedal
* Madeline Rodriguez-Valentin
* Luz Nagle
* Ellen Scott
* Ben Schachner
* Patrick Innamarato
* Amy M. Hall
* Jamie Blauvelt
* Carolyn J. Rich
* Allison D. Richards
* Jake Ceccarelli
* TJ Langer
* Sean J. Yoder
* Matthew S. Beatty
* Cheryl A. Cox
* Jane L. Messina
* Daniel Abate-Daga
* James J. Mule
* John E. Mullinax
* Amod A. Sarnaik
* Shari Pilon-Thomas